| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Association between antibiotic-immunotherapy exposure ratio and outcome in metastatic non small cell lung cancer
|
Galli, Giulia
|
|
2019
|
132 |
C |
p. 72-78
|
artikel
|
| 2 |
Association of TP53 mutations with response and longer survival under immune checkpoint inhibitors in advanced non-small-cell lung cancer
|
Assoun, Sandra
|
|
2019
|
132 |
C |
p. 65-71
|
artikel
|
| 3 |
Cause-and-Effect relationship between FGFR1 expression and epithelial-mesenchymal transition in EGFR-mutated non-small cell lung cancer cells
|
Vad-Nielsen, Johan
|
|
2019
|
132 |
C |
p. 132-140
|
artikel
|
| 4 |
Characteristics of 252 patients with bronchopulmonary neuroendocrine tumours treated at the Copenhagen NET Centre of Excellence
|
Grøndahl, V.
|
|
2019
|
132 |
C |
p. 141-149
|
artikel
|
| 5 |
Clinical features and outcomes of pulmonary lymphoma: A single center experience of 180 cases
|
Zhang, Mu-Chen
|
|
2019
|
132 |
C |
p. 39-44
|
artikel
|
| 6 |
Comment on: 'Correlation of Tumor Spread through Air Spaces and Clinicopathological Characteristics in Surgically Resected Lung Adenocarcinomas'
|
Song, Tieniu
|
|
2019
|
132 |
C |
p. 150
|
artikel
|
| 7 |
Comparative effectiveness of multi-fraction stereotactic radiosurgery for surgically resected or intact large brain metastases from non-small-cell lung cancer (NSCLC)
|
Minniti, Giuseppe
|
|
2019
|
132 |
C |
p. 119-125
|
artikel
|
| 8 |
Contents
|
|
|
2019
|
132 |
C |
p. v-vii
|
artikel
|
| 9 |
Corrigendum to “Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall survival: A National Cancer Database Analysis” [Lung Cancer, Volume 130 (April) (2019) 162–168]
|
Foster, Corey C.
|
|
2019
|
132 |
C |
p. 159
|
artikel
|
| 10 |
Corrigendum to “Analysis of central nervous system efficacy in the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer” [Lung Cancer 121 (July) (2018) Pages 37–40]
|
Nishio, Makoto
|
|
2019
|
132 |
C |
p. 160
|
artikel
|
| 11 |
Corrigendum to “Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line treatment for stage IV squamous non-small cell lung cancer: A phase 1b and randomized, open-label, multicenter, phase 2 trial in Japan” [Lung Cancer, 129 (March) (2019) 55–62]
|
Watanabe, Satoshi
|
|
2019
|
132 |
C |
p. 157-158
|
artikel
|
| 12 |
Demography, patterns of care and survival outcomes in patients with malignant tumors of trachea: A systematic review and individual patient data analysis of 733 patients
|
Mallick, Supriya
|
|
2019
|
132 |
C |
p. 87-93
|
artikel
|
| 13 |
Editorial Board
|
|
|
2019
|
132 |
C |
p. iii
|
artikel
|
| 14 |
Epidermal growth factor receptor-targeted immunomagnetic liposomes for circulating tumor cell enumeration in non-small cell lung cancer treated with epidermal growth factor receptor-tyrosine kinase inhibitors
|
Cui, Shaohua
|
|
2019
|
132 |
C |
p. 45-53
|
artikel
|
| 15 |
High expression level of SOX2 is significantly associated with shorter survival in patients with thymic epithelial tumors
|
Lee, Guk Jin
|
|
2019
|
132 |
C |
p. 9-16
|
artikel
|
| 16 |
Lung cancer incidence in female rises significantly in urban sprawl of Shanghai after introduction of LDCT screening
|
Liang, Fei
|
|
2019
|
132 |
C |
p. 114-118
|
artikel
|
| 17 |
Lymphangitic carcinomatosis: A common radiographic manifestation of local failure following extended pleurectomy/decortication in patients with malignant pleural mesothelioma
|
Berger, Ian
|
|
2019
|
132 |
C |
p. 94-98
|
artikel
|
| 18 |
Oral maintenance metronomic vinorelbine versus best supportive care in advanced non-small-cell lung cancer after platinum-based chemotherapy: The MA.NI.LA. multicenter, randomized, controlled, phase II trial
|
Platania, Marco
|
|
2019
|
132 |
C |
p. 17-23
|
artikel
|
| 19 |
Patients with SMARCA4-deficient thoracic sarcoma and severe skeletal-related events
|
Kunimasa, Kei
|
|
2019
|
132 |
C |
p. 59-64
|
artikel
|
| 20 |
Predictive value of serum protein levels in patients with advanced non-small cell lung cancer treated with nivolumab
|
Oyanagi, Jun
|
|
2019
|
132 |
C |
p. 107-113
|
artikel
|
| 21 |
Radiomics signature: A potential and incremental predictor for EGFR mutation status in NSCLC patients, comparison with CT morphology
|
Tu, Wenting
|
|
2019
|
132 |
C |
p. 28-35
|
artikel
|
| 22 |
Randomized phase II study of pemetrexed or pemetrexed plus bevacizumab for elderly patients with previously untreated non-squamous non-small cell lung cancer: Results of the Lung Oncology Group in Kyushu (LOGIK1201)
|
Fukuda, Minoru
|
|
2019
|
132 |
C |
p. 1-8
|
artikel
|
| 23 |
Re-administration of osimertinib in osimertinib-acquired resistant non-small-cell lung cancer
|
Ichihara, Eiki
|
|
2019
|
132 |
C |
p. 54-58
|
artikel
|
| 24 |
Response to comment on: “Correlation of Tumor Spread through Air Spaces and Clinicopathological Characteristics in Surgically Resected Lung Adenocarcinomas.”
|
Hsieh, Min-Shu
|
|
2019
|
132 |
C |
p. 151
|
artikel
|
| 25 |
Sequencing of therapy following first-line afatinib in patients with EGFR mutation-positive non-small cell lung cancer
|
Park, Keunchil
|
|
2019
|
132 |
C |
p. 126-131
|
artikel
|
| 26 |
Somatic mutation of LRP1B is associated with tumor mutational burden in patients with lung cancer
|
Lan, Shaowei
|
|
2019
|
132 |
C |
p. 154-156
|
artikel
|
| 27 |
The incidence of ALK inhibitor-related pneumonitis in advanced non-small-cell lung cancer patients: A systematic review and meta-analysis
|
Suh, Chong Hyun
|
|
2019
|
132 |
C |
p. 79-86
|
artikel
|
| 28 |
The metastatic site does not influence PD-L1 expression in advanced non-small cell lung carcinoma
|
Wang, H.
|
|
2019
|
132 |
C |
p. 36-38
|
artikel
|
| 29 |
The novel microRNA hsa-miR-CHA1 regulates cell proliferation and apoptosis in human lung cancer by targeting XIAP
|
Yoo, Jung Ki
|
|
2019
|
132 |
C |
p. 99-106
|
artikel
|
| 30 |
The role of radiation treatment in pleural mesothelioma: Highlights of the 14th International Conference of the International mesothelioma interest group
|
MacRae, Robert M
|
|
2019
|
132 |
C |
p. 24-27
|
artikel
|
| 31 |
What impacts the cost-effectiveness of PD-L1 testing in non-small cell lung cancer?
|
Bravaccini, Sara
|
|
2019
|
132 |
C |
p. 152-153
|
artikel
|
Tijdschrift beschrijving